Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial

BACKGROUND: Intravitreal triamcinolone acetonide (IVTA) is an effective treatment for recalcitrant diabetic macular oedema (DMO). It has been shown to improve vision with benefits persisting up to five years. The most common initial side effect of IVTA treatment is rise in intraocular pressure, occu...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Day, Roderick F, Barthelmes, Daniel, Zhu, Meidong, Wong, Tien Y, McAllister, Ian L, Arnold, Jennifer J, Gillies, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223852/
https://www.ncbi.nlm.nih.gov/pubmed/25335434
http://dx.doi.org/10.1186/1471-2415-14-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223852/
https://www.ncbi.nlm.nih.gov/pubmed/25335434
http://dx.doi.org/10.1186/1471-2415-14-123

Ejemplares similares